Q2 EPS Estimates for PDS Biotechnology Increased by B. Riley
PDS Biotechnology Co. (NASDAQ:PDSB – Free Report) – Equities research analysts at B. Riley upped their Q2 2025 earnings per share (EPS) estimates for PDS Biotechnology in a note issued to investors on Monday, May 19th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings per share of ($0.23) for the […]
PDS Biotechnology Co. (NASDAQ:PDSB – Free Report) – Equities research analysts at B. Riley upped their Q2 2025 earnings per share (EPS) estimates for PDS Biotechnology in a note issued to investors on Monday, May 19th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings per share of ($0.23) for the […]
